Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 17, Issue 3, Pages 375-385
Publisher
Informa UK Limited
Online
2017-01-27
DOI
10.1080/14712598.2017.1285903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial
- (2016) P. Staubach et al. ALLERGY
- ‘Real-life’ effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review
- (2016) I. Abraham et al. ALLERGY
- Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis
- (2016) S. Guillén-Aguinaga et al. BRITISH JOURNAL OF DERMATOLOGY
- Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
- (2016) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
- (2016) Zuo-Tao Zhao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
- (2016) Ana M. Gimenéz-Arnau et al. Clinical and Translational Allergy
- Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey
- (2015) Jeffrey Vietri et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Outcomes of using omalizumab for more than 1 year in refractory chronic urticaria
- (2015) Daniel Har et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Correlation between changes in urticaria symptoms and sleep experience in patients with chronic spontaneous/idiopathic urticaria (CSU/CIU): A post-hoc analysis from 2 randomized, double-blind, placebo-controlled phase 3 trials of omalizumab
- (2015) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu)
- (2015) M Balp et al. VALUE IN HEALTH
- Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients– Findings From The First International Burden of Illness Study (Assure-Csu)
- (2015) H Tian et al. VALUE IN HEALTH
- Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy
- (2015) Thomas B. Casale et al. Journal of Allergy and Clinical Immunology-In Practice
- Side Effects of Short-Term Oral Corticosteroids
- (2015) Robert N. Richards JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis
- (2015) Tianwen Lai et al. Scientific Reports
- Methods report on the development of the 2013 revision and update of the EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria
- (2014) T. Zuberbier et al. ALLERGY
- The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
- (2014) T. Zuberbier et al. ALLERGY
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
- (2014) Karsten Weller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria
- (2014) Martin Metz et al. JAMA Dermatology
- Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice
- (2013) Moises Labrador-Horrillo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Urticaria
- (2013) Brigid F. O’Donnell IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and construct validation of the angioedema quality of life questionnaire
- (2012) K. Weller et al. ALLERGY
- Omalizumab is effective in nonautoimmune urticaria
- (2011) Marta Ferrer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria
- (2011) Sarbjit Saini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
- (2011) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1
- (2010) M. Maurer et al. ALLERGY
- THERAPEUTIC ALTERNATIVES FOR CHRONIC URTICARIA: ADDITIONAL REPORTS ON OMALIZUMAB
- (2010) Sheldon L. Spector et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Maintenance of Remission With Low-Dose Omalizumab in Long-Lasting, Refractory Chronic Urticaria
- (2010) Ciro Romano et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- EAACI/GA²LEN/EDF/WAO guideline: management of urticaria
- (2009) T. Zuberbier et al. ALLERGY
- The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings
- (2009) A. Młynek et al. ALLERGY
- Omalizumab in severe chronic urticaria
- (2009) KV Godse Indian Journal of Dermatology Venereology & Leprology
- The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
- (2009) Stephen Holgate et al. RESPIRATORY MEDICINE
- Chronic autoimmune urticaria : Where we stand ?
- (2009) CL Goh et al. INDIAN JOURNAL OF DERMATOLOGY
- Effect of Anti-IgE (Omalizumab) in Chronic Idiopathic Urticaria (CIU) Patients
- (2008) L GOBER et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of chronic autoimmune urticaria with omalizumab
- (2008) Allen P. Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started